Skip to main content
. 2022 Jun 16;14(6):1283. doi: 10.3390/pharmaceutics14061283

Table 5.

Drug binding to plasma proteins in vitro and in vivo within the brain capillary.

Drug Plasma Protein KDin vitro (μM) KDin vivo (μM) Reference
propranolol bovine albumin 299 ± 25 220 ± 40 [1102]
AAG 3.3 ± 0.1 19 ± 4
bupivacaine bovine albumin 141 ± 10 211 ± 107 [1113]
AAG 6.5 ± 0.5 17 ± 4
piroxicam human albumin 10.9 ± 0.1 910 ± 105 [1114]
AAG 29 ± 1 35 ± 3
diazepam bovine albumin 2 13,900 [1115]
human albumin 6.3 ± 0.1 156 ± 35 [1116]
devazepide human albumin 8.2 ± 0.8 266 ± 38
imipramine AAG 4.9 ± 0.3 90 ± 9 [1117]
isradipine human albumin 62 ± 8 221 ± 7 [1118]
AAG 6.9 ± 0.9 35 ± 2
darodipine human albumin 94 ± 5 203 ± 14
AAG 2.5 ± 0.5 55 ± 7
domitroban bovine albumin 35 36 ± 4 [1115]
L-tryptophan bovine albumin 130 ± 30 1700 ± 100 [1119]
L-T3 bovine albumin 4.7 ± 0.1 46 ± 4 [1100]
testosterone bovine albumin 53 ± 1 2520 ± 710 [1100]

AAG = human α1-acid glycoprotein; assumes 1 drug binding site on each plasma protein.